Evidence map›Paper›PMID 40673049›Full record

ArticleJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada2025

Surveillance for Health Care-Associated Infections, Antimicrobial Resistant Organisms and Antimicrobial use in Canadian Long-Term Care Homes: A Cross-Sectional Survey.

Jessica J Bartoszko, Andrew Neitzel, Zainab Suleman, Tamara Duncombe, George Golding, Jennifer Happe, Alexandra C McFarlane, Allison McGeer, Marjorie Belzile, Christine Cohoon and 14 more

Abstract read
In one paragraph

Article in Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Jessica J BartoszkoCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Andrew NeitzelCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Zainab SulemanCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Tamara DuncombeInfection Prevention and Control, Fraser Health, Surrey, British Columbia, Canada.
George GoldingNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Jennifer HappeInfection Prevention and Control, Alberta Children's Hospital, Calgary, Alberta, Canada.
Alexandra C McFarlaneDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Allison McGeerDepartment of Microbiology, Sinai Health, Toronto, Ontario, Canada.
Marjorie BelzileInfection Prevention and Control Canada Long-Term Care Interest Group, Winnipeg, Manitoba, Canada.
Christine CohoonDepartment of Social Development, Government of New Brunswick, Fredericton, New Brunswick, Canada.
Youhanna SalibInfection Prevention and Control, Extendicare, Markham, Ontario, Canada.
Julie WeirNew Brunswick Association of Nursing Homes, Fredericton, New Brunswick, Canada.
Jennie JohnstoneDepartment of Microbiology, Sinai Health, Toronto, Ontario, Canada.
Ramona RodriguesInfection Prevention and Control, Montreal West Island Integrated University Health and Social Services Centre, Montreal, Quebec, Canada.
Barbara CattCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Kelly ChoiCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Svjetlana CrkvenjasInfection Prevention and Control, Alberta Health Services, Edmonton, Alberta, Canada.
Lunadel DaclanQuality, Risk and Infection Prevention and Control, Louis Brier Home and Hospital, Vancouver, British Columbia, Canada.
Yvette GableInfection Prevention and Control, Alberta Health Services, Edmonton, Alberta, Canada.
Robyn MitchellCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Kathryn SuhInfection Prevention and Control, The Ottawa Hospital, Ottawa, Ontario, Canada.
Esther ThompsonInfection Prevention and Control, Vancouver Coastal Health, Vancouver, British Columbia, Canada.
B Lynn JohnstonCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Olivia VarsaneuxCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Our understanding of health care-associated infection (HAI), antimicrobial resistant organism (ARO), and antimicrobial use (AMU) surveillance activities across Canadian long-term care homes (LTCHs) is limited, in part because nationwide surveillance in this setting has yet to be established. Methods: To address this knowledge gap, the Canadian Nosocomial Infection Surveillance Program administered a 12-item cross-sectional survey to LTCHs across all provinces and territories in English and French. LTCHs were defined as government-licensed homes for individuals with medical needs who require 24-hour onsite access to registered nurse care and/or treatment. Results: Between June 1 and November 28, 2023, 770 of an estimated 2,076 LTCHs responded to the survey (37%). Of the respondents, 41% (318/770) were publicly funded, 67% (504/758) had between 51 and 200 long-term care beds, and 92% (694/758) reported having a designated person who leads infection prevention and control. The majority of LTCHs reported conducting outbreak surveillance (680/713, 95%) and surveillance for at least one type of HAI (672/740, 91%). The most common HAIs under surveillance were urinary tract infection (576/725, 79%), Conclusions: Despite differences in the scope of surveillance activities, mechanisms to measure the burden of HAIs and AROs in this setting exist and may provide the foundation for future national surveillance activities. Generalizability to all Canadian LTCHs is uncertain due to possible sampling, non-response, and social desirability biases.

Indexed as

antimicrobial resistance (AMR)antimicrobial resistant organisms (AROs)antimicrobial use (AMU)health care–associated infections (HAIs)infection prevention and control (IPAC)surveillance

Identifiers

PMID40673049
PMCPMC12253937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.